Research status of tumor nodules in colorectal cancer

Abstract

Liu Hongyan, Li Yunfeng, Chen Honggang, Yang Guochun. Research status of tumor nodules in colorectal cancer[J]. Journal of International Oncology, 2016, 43(11): 868-870.

［1］ Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014［J］. CA Cancer J Clin, 2014, 64(1): 9-29. DOI: 10.3322/caac.21208. ［2］ Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual［M］. 7th ed. New York: Springer, 2010. ［3］ Wünsch K, Müller J, Jhnig H, et al. Shape is not associated with the origin of pericolonic tumor deposits［J］. Am J Clin Pathol， 2010， 133(3): 388-394. DOI: 10.1309/AJCPAWOLX7ADZQ2K. ［4］ Fan XJ, Wan XB, Yang ZL, et al. Snail promotes lymph node metastasis and Twist enhances tumor deposit formation through epithelialmesenchymal transition in colorectal cancer［J］. Hum Pathol, 2013, 44(2): 173-180. DOI: 10.1016/j. humpath. 2012.03.029. ［5］ Zhang D, Zheng L, Shi H, et al. Suppression of peritoneal tumorigenesis by placentaderived mesenchymal stem cells expressing endostatin on colorectal cancer［J］. Int J Med Sci, 2014, 11(9): 870-879. DOI: 10.7150/ijms.8758. ［6］ Koelzer VH, Lugli A, Dawson H, et al. CD8/CD45RO T cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival［J］. J Transl Med, 2014, 12: 81. DOI: 10.1186/1479-5876-12-81. ［7］ Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging handbook［M］. 6th ed. New York: Springer, 2002: 104-109. ［8］ Song YX, Gao P, Wang ZN, et al. Can the tumor deposits be counted as metastatic lymph nodes in the UICC TNM staging system for colorectal cancer?［J］. PLoS One, 2012, 7(3): e34087. DOI: 10.1371/journal.pone.0034087. ［9］ Ueno H, Mochizuki H, Shirouzu K, et al. Multicenter study for optimal categorization of extramural tumor deposits for colorectal cancer staging［J］. Ann Surg, 2012, 255(4): 739-746. DOI: 10.1097/SLA.0b013e31824b4839. ［10］ Ueno H1, Mochizuki H, Shirouzu K, et al. Actual status of distribution and prognostic impact of extramural discontinuous cancer spread in colorectal cancer［J］. J Clin Oncol, 2011, 29(18): 25502556. DOI: 10.1200/JCO.2010.33.7725. ［11］ Nagtegaal ID,Tot T,Jayne DG, et al. Lymph nodes, tumor deposits, and TNM: are we getting better?［J］. J Clin Oncol, 2011, 29(18): 2487-2492. DOI: 10.1200/JCO.2011.34.6429. ［12］ Ueno H, Hashiguchi Y, Shimazaki H, et al. Peritumoral deposits as an adverse prognostic indicator of colorectal cancer［J］. Am J Surg, 2014, 207(1): 7077. DOI: 10.1016/j.amjsurg. 2013.04.009. ［13］ Tong LL, Gao P, Wang ZN, et al. Is the seventh edition of the UICC/AJCC TNM staging system reasonable for patients with tumor deposits in colorectal cancer?［J］. Ann Surg, 2012, 255(2): 208-213. DOI: 10.1097/SLA.0b013e31821ad8a2. ［14］ Nagayoshi K, Ueki T, Nishioka Y, et al. Tumor deposit is a poor prognostic indicator for patients who have stage Ⅱ and Ⅲ colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more［J］. Dis Colon Rectum, 2014, 57(4): 467-474. DOI: 10.1097/DCR.0000000000000059. ［15］ Lin Q, Wei Y, Ren L, et al. Tumor deposit is a poor prognostic indicator in patients who underwent simultaneous resection for synchronous colorectal liver metastases［J］. Onco Targets Ther, 2015, 8: 233-240. DOI: 10.2147/OTT.S71414.eCollection 2015. ［16］ Song JS, Chang HJ, Kim DY, et al. Is the N1c category of the new American Joint Committee on cancer staging system applicable to patients with rectal cancer who receive preoperative chemora therapy?［J］. Cancer, 2011, 117(17): 3917-3924. DOI: 10.1002/cncr.25968. ［17］ Gopal P, Lu P, Ayers GD, et al. Tumor deposits in rectal adenocarcinoma after neoadjuvant chemoradiation are associated with poor prognosis［J］. Mod Pathol, 2014, 27(9): 1281-1287. DOI: 10.1038/modpathol.2013.239.

[1]	Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[4]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[5]	Fan Zhipeng, Yu Jing, Hu Jing, Liao Zhengkai, Xu Yu, Ouyang Wen, Xie Conghua.Predictive value of changes in inflammatory markers for prognosis in patients with advanced non-small cell lung cancer treated with the first-line immunotherapy plus chemotherapy[J]. Journal of International Oncology, 2024, 51(5): 257-266.
[6]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[7]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[8]	Liu Pingping, He Xuefang, Zhang Yi, Yang Xu, Zhang Shanshan, Ji Yifei.Risk factors of postoperative recurrence in patients with primary brain glioma and prediction model construction[J]. Journal of International Oncology, 2024, 51(4): 193-197.
[9]	Wan Fang, Yang Gang, Li Rui, Wan Qijing.Expression levels and clinical significance of serum miR-497 and miR-383 in patients with esophageal cancer[J]. Journal of International Oncology, 2024, 51(4): 204-209.
[10]	Yao Yixin, Shen Yulin.Predictive value of serum SOCS3 and TXNIP levels for the prognosis of patients with hepatocellular carcinoma treated with TACE[J]. Journal of International Oncology, 2024, 51(4): 217-222.
[11]	Sun Weiwei, Yao Xuemin, Wang Pengjian, Wang Jing, Jia Jinghao.Exploration of prognostic factors and nomogram construction for advanced non-small cell lung cancer treated with immunotherapy based on hematologic indexes[J]. Journal of International Oncology, 2024, 51(3): 143-150.
[12]	Liu Yulan, Jing Haiyan, Sun Jing, Song Wei, Sha Dan.Advances in predicting efficacy and prognostic markers of immunotherapy for gastric cancer[J]. Journal of International Oncology, 2024, 51(3): 175-180.
[13]	Peng Qin, Cai Yuting, Wang Wei.Advances on KPNA2 in liver cancer[J]. Journal of International Oncology, 2024, 51(3): 181-185.
[14]	Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan.Research progress on the histopathological growth patterns of colorectal liver metastasis[J]. Journal of International Oncology, 2024, 51(2): 114-118.
[15]	Chen Boguang, Wang Sugui, Zhang Yongjie.Role of serum cholinesterase and inflammatory markers in the prognosis of stage ⅠA -ⅢA breast cancer[J]. Journal of International Oncology, 2024, 51(2): 73-82.

Research status of tumor nodules in colorectal cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments